India Restricts Exports of Antifungal Injections Used to Treat Infections
India imposed export restrictions on injections of amphotericin-b, an antifungal medication used to treat certain infections, the country’s Directorate General of Foreign Trade said June 1. The injection falls under the Indian Trade Classification Harmonized System codes 30049029 and 30049099.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.